A 6‑week pregnant woman with a surgically closed patent ductus arteriosus at age 2 (left axillary scar), currently asymptomatic and without murmur—what is the recommended cardiac evaluation and management during pregnancy and what are the associated risks?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Pregnant Woman with Surgically Closed PDA

A pregnant woman at 6 weeks gestation with a surgically closed PDA at age 2, who is currently asymptomatic without murmur, requires baseline echocardiographic evaluation to confirm complete closure and assess cardiac function, followed by routine prenatal care with low-risk pregnancy management if the ductus is confirmed closed. 1

Initial Cardiac Evaluation

Perform transthoracic echocardiography early in pregnancy to confirm:

  • Complete closure of the PDA with no residual shunt 2
  • Absence of left atrial or left ventricular enlargement 2
  • Normal biventricular function 1
  • Pulmonary artery pressures 2
  • Assessment for any associated cardiac abnormalities 1

The absence of a murmur on clinical examination is reassuring but does not exclude residual shunt or other cardiac issues, making echocardiography essential 2. The left axillary scar suggests surgical ligation via thoracotomy, which typically results in complete closure 1.

Risk Stratification

If PDA is Completely Closed (Most Likely Scenario):

This patient should be classified as low cardiac risk for pregnancy 1. The European Society of Cardiology guidelines indicate that:

  • Successfully repaired simple congenital heart lesions without residual defects carry minimal pregnancy risk 1
  • Pregnancy is well tolerated after complete PDA closure 1
  • No specific cardiac restrictions are needed during pregnancy 1

Maternal Risks with Complete Closure:

  • Negligible increased cardiovascular risk compared to general population 1
  • Standard obstetric risks apply 1
  • No increased risk of arrhythmias or heart failure 1

Fetal/Neonatal Risks:

  • Slightly increased risk of congenital heart disease in offspring (3-5% vs 1% in general population) 1
  • Consider fetal echocardiography at 18-22 weeks gestation 1

Management During Pregnancy

Surveillance Protocol:

  • Repeat echocardiography once per trimester if initial study confirms complete closure and normal function 1
  • Clinical assessment at each prenatal visit for symptoms of heart failure (dyspnea, orthopnea, edema) 1
  • No activity restrictions if cardiac function is normal 1

Delivery Planning:

  • Vaginal delivery is recommended as the preferred mode 1
  • Cesarean section only for obstetric indications 1
  • Standard labor analgesia is appropriate 1
  • No endocarditis prophylaxis required for delivery, even with membrane rupture, as completely repaired PDA without residual defects does not warrant prophylaxis 1, 2

Critical Pitfall to Avoid

Do not assume complete closure based solely on absence of murmur - a "silent" residual PDA can exist without audible findings 2. Echocardiography is mandatory to document complete closure 2.

If Residual PDA is Discovered:

Should echocardiography reveal an unexpected residual shunt, management depends on hemodynamic significance:

  • Small residual PDA without left heart enlargement: Continue pregnancy with increased surveillance (monthly echocardiograms) 1, 2
  • Hemodynamically significant PDA with left heart enlargement: Consider transcatheter device closure before 20 weeks if technically feasible, or medical management with close monitoring 1
  • Avoid NSAIDs after 20 weeks gestation due to risk of premature ductal closure in the fetus 1

Postpartum Considerations

  • Clinical and echocardiographic reassessment at 6 weeks postpartum 1
  • Genetic counseling regarding recurrence risk in future pregnancies 1
  • No long-term cardiac restrictions if closure remains complete 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hemodynamically and Clinically Stable Patent Ductus Arteriosus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is persistent ductus arteriosus (PDA) in premature infants?
How does the persistence of an anomalous ductus arteriosus (PDA) or its inadequate involution influence the pathophysiology of congenital heart disease?
What is patent ductus arteriosus (PDA), the significance of a displaced point of maximal impulse (PMI), and the anatomy of the heart including atria, ventricles, and valves?
What is the diagnosis and treatment for a child with a continuous machinery murmur heard best at the second left intercostal space?
What is the initial treatment for a 2-4 day old neonate with apnea, machinery murmur, wide pulse pressure, and bilateral wet lungs on chest X-ray (CXR), suggestive of a patent ductus arteriosus (PDA)?
My fertile window opened today on cycle day 11 with estrone‑3‑glucuronide (E1G) 38.3 ng/mL and pregnanediol‑glucuronide (PdG) 6.5 µg/mL; when will the luteinizing hormone (LH) surge occur?
Can citicoline (CDP‑choline) be used as adjunctive therapy after a transient ischemic attack or mild ischemic stroke in an adult, and what is the recommended dosing?
Can a healthy adult use taurine to prevent transient ischemic attack or mild ischemic stroke, and what is the safe dosage and contraindications such as renal impairment?
What oral regimen should be used to treat early and late syphilis in non‑pregnant patients without severe penicillin allergy, including dosing and alternatives?
How is base excess defined, what are normal values, and how does it guide management of hemorrhagic shock, septic shock, and diabetic ketoacidosis?
In a female patient with rapid (3‑4 month) onset of severe Cushingoid features, marked hypercortisolism and elevated ACTH, how can we differentiate a pituitary ACTH‑secreting adenoma (Cushing disease) from an ectopic ACTH‑producing tumor?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.